Group 1 - Orion Corporation has converted 301,521 A shares into B shares, with the conversion recorded in the Trade Register on May 2, 2025 [1] - After the conversion, the total number of shares in Orion Corporation is 141,134,278, consisting of 32,450,742 A shares and 108,683,536 B shares [1] - The total number of votes for the company's shares after the conversion is 757,698,376 [1] Group 2 - Orion Corporation is a Nordic pharmaceutical company with over a hundred years of experience, focusing on developing, manufacturing, and marketing human and veterinary pharmaceuticals [2] - In 2024, Orion's net sales reached EUR 1,542 million, and the company employed approximately 3,700 professionals globally [2] - The core therapy areas of Orion's pharmaceutical R&D include oncology and pain, with proprietary products aimed at treating cancer, neurological diseases, and respiratory diseases [2]

Revenue Performance - Total contract revenues for the three months ended March 31, 2025, were $188.7 million, a 17.4% increase from $160.7 million in the same period of 2024[32] - Marine segment contract revenues increased to $127.2 million in Q1 2025 from $106.3 million in Q1 2024, representing a 19.6% growth[32] - Concrete segment contract revenues rose to $61.5 million in Q1 2025, up from $54.3 million in Q1 2024, marking a 13.5% increase[32] - Contract revenues generated outside the United States accounted for 6.3% of total revenues in Q1 2025, compared to 6.0% in Q1 2024[38] - The Company reported a total of $1.0 million in intersegment revenues between its marine and concrete segments for the three months ended March 31, 2025[85] Financial Position - As of March 31, 2025, the aggregate amount of remaining performance obligations was approximately $839.7 million, with an expectation to recognize $644.7 million, or 77%, in the next 12 months[41] - The Company incurred costs on uncompleted contracts totaling $1.5 billion as of March 31, 2025, down from $1.6 billion at December 31, 2024[39] - The allowance for credit losses was $787,000 as of March 31, 2025, compared to $555,000 at December 31, 2024[35] - As of March 31, 2025, total accrued liabilities decreased to $20.3 million from $26.3 million as of December 31, 2024, representing a reduction of approximately 22.8%[50] - Total debt as of March 31, 2025, was $26.7 million, slightly down from $26.8 million as of December 31, 2024[50] - Other long-term liabilities decreased to $19.7 million as of March 31, 2025, from $20.5 million as of December 31, 2024[66] Expenses and Costs - Depreciation expense for the three months ended March 31, 2025, was $3.2 million, compared to $4.2 million for the same period in 2024[42] - Total lease costs for the three months ended March 31, 2025, amounted to $7.005 million, compared to $6.114 million in 2024, indicating an increase of 14.6%[88] - The Company recorded an income tax expense of $140,000 for the three months ended March 31, 2025, with an effective tax rate of (11.0)%, compared to a benefit of $352,000 and an effective rate of 5.5% for the same period in 2024[72] Shareholder Information - Basic earnings per share for the three months ended March 31, 2025, was based on 39,056,396 weighted average shares outstanding, compared to 32,553,750 for the same period in 2024[76] - The Company issued 71,133 shares under the Employee Stock Purchase Plan (ESPP) during the three months ended March 31, 2025, generating proceeds of $0.3 million[78] - The Company has reserved a total of 1,000,000 shares under the ESPP, all authorized and available for future issuance[78] Credit and Debt Agreements - The Company entered into a Credit Agreement on May 15, 2023, providing for a $65.0 million asset-based revolving credit facility and a $38.0 million fixed asset term loan, maturing on May 15, 2028[51] - The quarterly weighted average interest rate for the Credit Agreement was 11.25% as of March 31, 2025, down from 13.09% in the same period of 2024[55] - The Company had $23.0 million in outstanding borrowings under its Credit Agreement as of March 31, 2025, with a weighted average interest rate of 10.94%[132] Segment Analysis - The Company has determined it has two reportable segments, with contract revenues disaggregated by service line for better financial analysis[32] - The gross profit margin for the marine segment improved to 14.6% in Q1 2025 from 5.8% in Q1 2024[85] - The Company granted 293,073 performance-based units to executives on March 20, 2025, with a fair value of $5.89 per share related to adjusted EBITDA targets[80] - Total share-based compensation expense for the three months ended March 31, 2025, was $1.123 million, compared to $0.358 million for the same period in 2024, representing an increase of 213%[79]

Orion Group (ORN) Q1 2025 Earnings Call April 30, 2025 09:00 AM ET Speaker0 Good day, and welcome to the Orion Group Holdings First Quarter twenty twenty five Conference Call. All participants will be in listen only mode. After today's presentation, there will be an opportunity to ask questions. Please note this event is being recorded. I would now like to turn the conference over to Margaret Boyce, Investor Relations. Please go ahead. Speaker1 Thank you, Michael, and thanks everyone for joining us today to ...

Core Insights - Orion Marine Group reported revenue of $188.65 million for the quarter ended March 2025, reflecting a year-over-year increase of 17.4% and surpassing the Zacks Consensus Estimate by 8.70% [1] - The company's EPS for the quarter was $0.01, a significant improvement from -$0.12 in the same quarter last year, resulting in an EPS surprise of 109.09% compared to the consensus estimate of -$0.11 [1] Revenue Breakdown - Concrete Segment contract revenues were $61.49 million, exceeding the average estimate of $56.30 million by analysts, marking a year-over-year increase of 13.1% [4] - Marine Segment contract revenues reached $127.16 million, surpassing the average estimate of $109.42 million, with a year-over-year growth of 19.6% [4] Operating Income Analysis - The Concrete Segment reported an operating loss of $3.95 million, which was worse than the average estimate of a loss of $0.58 million from analysts [4] - In contrast, the Marine Segment achieved an operating income of $4.78 million, significantly better than the average estimate of a loss of $3.54 million [4] Stock Performance - Over the past month, shares of Orion Marine have returned +16.4%, outperforming the Zacks S&P 500 composite, which saw a decline of -0.8% [3] - Despite the recent performance, the stock currently holds a Zacks Rank 5 (Strong Sell), indicating potential underperformance in the near term [3]

Financial Performance - First quarter 2025 revenue increased 17% year-over-year to $189 million, with Adjusted EBITDA doubling to $8.2 million[4][6] - Contract revenues rose 17.4% to $188.7 million compared to $160.7 million in the same quarter last year[6][7] - GAAP net loss narrowed to $1.4 million ($0.04 per diluted share) from a loss of $6.1 million ($0.19 per diluted share) year-over-year[6][10] - Adjusted net income was $0.3 million ($0.01 per diluted share), compared to an adjusted net loss of $3.6 million ($0.11 per diluted share) in Q1 2024[6][10] - Adjusted net income for Q1 2025 was $260,000, compared to a loss of $3,592,000 in Q1 2024, reflecting a significant improvement[28] - Adjusted EBITDA for the three months ended March 31, 2025, was $8,166,000, a 100.5% increase from $4,074,000 in the same period of 2024[29] - The adjusted EBITDA margin improved to 4.3% in Q1 2025, compared to 2.5% in Q1 2024[29] Revenue and Backlog - New contract awards year-to-date totaled $349 million, with $161 million in Marine and $188 million in Concrete[5][6] - Total backlog increased to $839.7 million as of March 31, 2025, up from $729.1 million at the end of 2024[12] - Total contract revenues for the three months ended March 31, 2025, were $188,653,000, an increase of 17.4% from $160,672,000 in the same period of 2024[26] - The Marine segment generated total revenues of $127,163,000, up 19.6% from $106,325,000 in 2024, with public sector revenues increasing to $100,222,000, representing 78.8% of the segment[26] Guidance and Projections - The company reiterated full year 2025 revenue guidance of $800 million to $850 million and Adjusted EBITDA guidance of $42 million to $46 million[5] - Adjusted EBITDA guidance for the year ending December 31, 2025, is projected between $42,000,000 and $46,000,000[39] - Adjusted net income guidance for the year ending December 31, 2025, is estimated to be between $4,302,000 and $6,900,000[42] - Adjusted EPS is expected to range from $0.11 to $0.17 for the year ending December 31, 2025[42] Expenses and Profitability - Gross profit margin improved to 12.2% of revenue, up from 9.7% in Q1 2024, driven by better performance in the marine segment[8] - SG&A expenses increased to $22.5 million, representing 12.0% of total contract revenues, up from 11.8% in the prior year[9] - The Marine segment's adjusted EBITDA was $10,896,000, while the Concrete segment reported an adjusted EBITDA loss of $2,730,000 for the same period[32] Cash Flow and Liquidity - Cash flows used in operating activities for Q1 2025 were $(3,443,000), a significant improvement from $(22,825,000) in Q1 2024[34] - Cash, cash equivalents, and restricted cash at the end of Q1 2025 were $12,956,000, compared to $4,638,000 at the end of Q1 2024, showing improved liquidity[36] - Cash and cash equivalents decreased to $12,956,000 from $28,316,000, a significant decline of about 54.1%[37] Assets and Liabilities - Total current assets decreased slightly to $267,022,000 as of March 31, 2025, from $269,328,000 at December 31, 2024, representing a decline of approximately 0.9%[37] - Accounts receivable increased to $142,201,000, up from $106,304,000, indicating a growth of about 33.8%[37] - Total liabilities decreased to $265,477,000 from $266,638,000, a reduction of approximately 0.4%[37] - Current liabilities increased to $193,669,000 from $191,173,000, reflecting a rise of approximately 1.3%[37] - Long-term debt decreased slightly to $22,042,000 from $22,751,000, a reduction of approximately 3.1%[37] - Total stockholders' equity remained relatively stable at $150,833,000 compared to $150,679,000, showing a slight increase of about 0.1%[37] Subsequent Events - Subsequent to the quarter end, the company secured an additional $51.2 million in new contract wins[13]

HOUSTON, April 29, 2025 (GLOBE NEWSWIRE) -- Orion Group Holdings, Inc. (NYSE: ORN) (the “Company”), a leading specialty construction company, today reported its financial results for the first quarter ended March 31, 2025. Highlights for the quarter ended March 31, 2025: Contract revenues increased 17.4% to $188.7 million versus the prior year periodGAAP net loss of $1.4 million or $0.04 per diluted share compared to a GAAP net loss of $6.1 million or $0.19 per diluted share year-over-yearAdjusted net inco ...

MANITOWOC, Wis., April 14, 2025 (GLOBE NEWSWIRE) -- Orion Energy Systems, Inc. (Nasdaq: OESX) (Orion Lighting), a provider of energy-efficient LED lighting, electric vehicle (EV) charging stations and maintenance services solutions, today announced that Orion’s Board of Directors has appointed Orion Board member Sally A. Washlow as the Company’s Chief Executive Officer, replacing Michael H. Jenkins, who is leaving the company. Additionally, the Board promoted Orion EVP and President of Orion Services Group, ...

Conference Call to be held Wednesday, April 30 at 8:00 a.m. Central TimeHOUSTON, April 07, 2025 (GLOBE NEWSWIRE) -- Orion Group Holdings, Inc. (NYSE: ORN), a leading specialty construction company, today announced that it will issue its first quarter 2025 financial results after the close of the stock market on Tuesday, April 29, 2025. A conference call and audio webcast with analysts and investors will be held the next day, Wednesday, April 30 at 9:00 a.m. Eastern Time/8:00 a.m. Central Time to discuss the ...

VANCOUVER, BC, March 31, 2025 /PRNewswire/ - WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) ("WELL" or the "Company"), a digital healthcare company focused on positively impacting health outcomes by leveraging technology to empower healthcare practitioners and their patients globally, announces that it intends to amend and exercise its call right (the "Call Right") and acquire a majority controlling interest in HEALWELL AI Inc. ("HEALWELL"), a healthcare artificial intelligence company focused on ...

The Valkyrie Trading Society is a team of analysts sharing high conviction and obscure developed market ideas that are downside limited and likely to generate non-correlated and outsized returns in the context of the current economic environment and forces. They are long-only investors. Analyst's Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it exp ...